Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Standard Biotools (LAB) Preferred Shares Issued (2022)

Standard Biotools has reported Preferred Shares Issued over the past 1 years, most recently at $202.7 million for Q2 2022.

Quarterly Preferred Shares Issued changed N/A to $202.7 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $202.7 million through Sep 2023, changed 0.0% year-over-year, with the annual reading at $225.0 million for FY2022, N/A changed from the prior year.
Preferred Shares Issued was $202.7 million for Q2 2022 at Standard Biotools.
Over five years, Preferred Shares Issued peaked at $202.7 million in Q2 2022 and troughed at $202.7 million in Q2 2022.